Expression level and glycan dynamics determine the net effects of timp-1 on cancer progression

BMB Reports

Volumn 45, Issue 11, 2012, Pages 623-628

  Kim, Yong Sam ^a   Kim, Sun Hee ^a   Kang, Jeong Gu ^a   Ko, Jeong Heon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Aberrant glycosylation; Cancer progression; MMP; TIMP 1; Tumor microenvironment

Indexed keywords

MATRIX METALLOPROTEINASE; POLYSACCHARIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; SHORT SURVEY;

ANIMALS; DISEASE PROGRESSION; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASMS; POLYSACCHARIDES; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84871404104     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.11.233     Document Type: Short Survey

References (51)

1. Bhowmick, N. A., Neilson, E. G. and Moses, H. L. (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432, 332-337.
2. Stetler-Stevenson, W. G., Aznavoorian, S. and Liotta, L. A. (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573.
3. Nagase, H. and Woessner, J. F. Jr. (1999) Matrix metalloproteinases. J. Biol. Chem. 274, 21491-21494.
4. Welgus, H. G., Jeffrey, J. J. and Eisen, A. Z. (1981) The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256, 9511-9515.
5. Hasty, K. A., Jeffrey, J. J., Hibbs, M. S. and Welgus, H. G. (1987) The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262, 10048-10052.
6. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. and Engler, J. A. (1993) Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197-250.
7. Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C. and Shi, Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30375-30380.
8. Laurent, G. J. and Tetley, T. D. (1984) Pulmonary fibrosis and emphysema: connective tissue disorders of the lung. Eur. J. Clin. Investig. 14, 411-413.
9. Gomis-Rueth, F., Maskos, K., Michael Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkovk, G. P., Bartunikk, H. and Bode, W. (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389, 77-81.
10. Varki, A. (1995) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130.
11. Moens, S. and Vanderleyden, J. (1997) Glycoproteins in prokaryotes. Arch. Microbiol. 168, 169-175.
12. Daniels, M. A., Hogquist, K. A. and Jameson, S. C. (2002) Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat. Immunol. 3, 903-910.
13. Dwek, M. V., Ross, H. A. and Leathem, A. J. (2001) Proteome and glycosylation mapping identifies post-translational modifications associated with aggressive breast cancer. Proteomics 1, 756-762.
14. Freeze, H. H. (2001) Update and perspectives on congenital disorders of glycosylation. Glycobiology 11, 129R-143R.
15. Thaysen-Andersen, M., ThØgersen, I. B., Lademann, U., Offenberg, H., Giessing, A. M. B., Enghild, J. J., Nielsen, H. J., Brünner, N. and HØjrup, P. (2008) Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases- 1. Biochim. Biophys. Acta 1784, 455-463.
16. Luparello, C., Avanzato, G., Carella, C. and Pucci-Minafra, I. (1999) Tissue inhibitor of metalloproteinases (TIMP-1) and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res. Treat. 54, 235-244.
17. Guedez, L., Stetler-Stevenson, W. G., Wolff, L., Wang, J., Fukushima, P., Mansoor, A. and Stetler-Stevenson, M. (1998) In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J. Clin. Invest. 102, 2002-2010.
18. Li, G., Fridman, R. and Kim, H. R. (1999) Tissue inhibitor of metalloproteinases-1 inhibits apoptosis of human breast epithelial cells. Cancer Res. 59, 6267-6275.
19. Jung, K., Nowak, L., Lein, M., Henke, W., Schnorr, D. and Loening, S. A. (1996) What kind of specimen should be selected for determining tissue inhibitor of metalloproteinase- 1 (TIMP-1) in blood? Clin. Chim. Acta 254, 97-100.
20. Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C. and Yuenian E. Shi, Y. E. (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase4. J. Biol. Chem. 271, 30375-30380.
21. Docherty, A. J., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J., Murphy, G. and Reynolds, J. J. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318, 66-69.
22. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M. and Docherty, A. J. P. (1991) The N-terminal domain of human tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30, 8097-8102.
23. Huang, W., Suzuki, K., Nagase, H., Arumugan, S., Van Doren, S. R. and Brew, K. (1996) Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinase-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett. 384, 155-161.
24. Stahl, B., Klabunde, T., Witzel, H., Krebs, B., Steup, M., Karas, M. and Hillenkamp, F. (1994) The oligosaccharides of the Fe(III)-Zn(II) purple acid-phosphatase of the red kidney bean-determination of the structure by a combination of matrix-assisted laser-desorption ionization mass spectrometry and selective enzymatic degradation. Eur. J. Biochem. 220, 321-330.
25. Mortz, E., Sareneva, T., Haebel, S., Julkunen, I. and Roepstorff, P. (1996) Mass spectrometric characterization of glycosylated interferon-variants separated by gel electrophoresis. Electrophoresis 17, 925-931.
26. Garner, B., Merry, A. H., Royle, L., Harvey, D. J., Rudd, P. M. and Thillet, J. (2001) Structural elucidation of the Nand O-glycans of human apolipoprotein(a): role of O-glycans in conferring protease resistance. J. Biol. Chem. 276, 200-208.
27. Larsen, M. R., HØjrup, P. and Roepstorff, P. (2005) Characterization of gel-separated glycoproteins using two-step proteolytic digestion combined with sequential microcolumns and mass spectrometry. Mol. Cell. Proteomics 4, 107-119.
28. Bunkenborg, J., Pilch, B. J., Podtelejnikov, A. V. and Wisniewski, J. R. (2004) Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 4, 454-465.
29. Holten-Andersen, M. N., Murphy, G., Nielsen, H. J., Pedersen A. N., Christensen, I. J., HØyer-Hansen, G., Brue nner, N. and Stephens, R. W. (1999) Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br. J. Cancer. 80, 495-503.
30. Sutton, C. W., O'Neill, J. A. and Cottrell, J. S. (1994) Sitespecific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry. Anal. Biochem. 218, 34-46.
31. Thaysen-Andersen, M., ThØgersen, I. B., Nielsen, H. J., Lademann, U., Nils Bruenner, N., Enghild, J. J. and Peter HØjrup, P. (2007) Rapid and individualspecific glycoprofiling of a low-abundant N-glycosylated protein tissue inhibitor of metalloproteinases-1. Mol. Cell. Proteomics 6, 638-647.
32. Kim, Y. S., Hwang, S. Y., Kang, H. Y., Sohn, H., Oh, S., Kim, J. Y., Yoo, J. S., Kim, Y. H., Kim, C. H., Jeon, J. H., Lee, J. M., Kang, H. A., Miyoshi, E., Taniguchi, N., Yoo, H. S. and Ko, J. H. (2008) Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase- 1. Mol. Cell. Proteomics 7, 1-14.
33. Whiteside, T. L. (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904-5912. 34. Lu, P., Weaver, V. M. and Werb, Z. (2012) The extracellular matrix. A dynamic niche in cancer progression. J. Cell Biol. 196, 395-406.
34. Lu, P., Weaver, V. M. and Werb, Z. (2012) The extracellular matrix. A dynamic niche in cancer progression. J. Cell Biol. 196, 395-406.
35. Kang, J G., Ko, J. H. and Kim, Y. S. (2011) Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer. BMB Rep. 44, 765-771.
36. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W., Yamauchi, M., Gasser, D. L. and Weaver, V. M. (2009) Matrix cross-linking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
37. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
38. Docherty, A. J., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J., Murphy, G. and Reynolds, J. J. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318, 66-69.
39. Taube, M. E., Liu, X. W., Fridman, R. and Kim H. R. (2006) TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27KIP1 protein. Oncogene 25, 3041-3048.
40. Bloomston, M., Shafii, A., Zervos, E. and Rosemurgy, A. S. (2005) TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo. Am. J. Surg. 189, 675-679.
41. Rho, S. B., Chung, B. M. and Lee, J. H. (2007) TIMP-1 regulates cell proliferation by interacting with the ninth zinc finger domain of PLZF. J. Cell. Biochem. 101, 57-67.
42. Fowell, A. J., Collins, J. E., Duncombe, D. R., Pickering, J. A., Rosenberg, W. M. and Benyon, R. C. (2011) Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation. Biochem. Biophys. Res. Commun. 407, 277-282.
43. Tsagaraki, I., Tsilibary, E. C. and Tzinia, A. K. (2010) TIMP-1 interaction with v3 integrin confers resistance to human osteosarcoma cell line MG-63 against TNF-a-induced apoptosis. Cell Tissue Res. 342, 87-96.
44. Davidsen, M. L., Wurtz, S. Ø., RØmer, M. U., SØrensen, N. M., Johansen, S. K., Christensen, I. J., Larsen, J. K., Offenberg, H., Brunner, N. and Lademann, U. (2006) TIMP-1 gene deficiency increases tumor cell sensitivity to chemotherapy- induced apoptosis. Br. J. Cancer 95, 114-120.
45. Khokha, R. (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J. Natl. Cancer Inst. 86, 299-304.
46. Martin, D. C., Ruther, U., Sanchez-Sweatman, O. H., Orr, F. W. and Khokha, R. (1996) Inhibition of SV40 T antigen- induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene 13, 569-576.
47. Aljada, I. S., Ramnath, N., Donohue, K., Harvey, S., Brooks, J. J., Wiseman, S. M., Khoury, T., Loewen, G., Slocum, H. K. anderson, T. M., Bepler, G. and Tan, D. (2004) Up-regulation of the tissue inhibitor of metalloproteinase- 1 protein is associated with progression of human non-small cell lung cancer. J. Clin. Oncol. 22, 3218-3229.
48. Korpi, J. T., Hagstrom, J., Lehtonen, N., Parkkinen, J., Sorsa, T., Salo, T. and Laitinen, M. (2011) Expression of matrix metalloproteinases-2, -8, -13, -26 and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg. Oncol. 20, e18-e22.
49. Inagaki, D., Oshima, T., Yoshihara, K., Tamura, S., Kanazawa, A., Yamada, T., Yamamoto, N., Sato, T., Shiozawa, M., Morinaga, S., Akaike, M., Fujii, S., Numata, K., Kunisaki, C., Rino, Y., Tanaka, K., Masuda, M. and Imada, T. (2010) Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer. Anticancer Res. 30, 4127-4130.
50. Kim, Y. S., Ahn, Y. H., Song, K. J., Jeong, G., Kang, J. G., Lee, J. H., Jeon, S. K., Kim, H. C., Yoo, J. S. and Ko, J. H. (2012) Overexpression and β-1,6-N-acetylglucosaminylation initiated aberrant glycosylation of TIMP-1. J. Biol. Chem. 287, 32467-32478.
51. Ahn, Y. H., Kim, Y. S., Ji, E. S., Lee, J. Y., Jung, J. A., Ko, J. H. and Jong S. Y. (2010) Comparative quantitation of aberrant glycoforms by lectin-based glycoprotein enrichment coupled with multiple-reaction monitoring mass spectrometry. Anal. Chem. 82, 4441-4447.